Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).
Flow Space on MSN48m
Dr. Sara Gottfried Shares Actionable Steps to Help Women With Chronic Illness Improve Overall Well-BeingAt the recent Eudēmonia Summit, Dr. Sara Gottfried explained why understanding the root cause of chronic illness is more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback